EN
HI
Summary
As of 12 Sep, 2026, Arvee Laboratories (India) stock price is ₹180.69. During the trading session, the stock has moved between an intraday low of ₹176.50 and an intraday high of ₹195.00. Over the last 52 weeks, Arvee Laboratories (India) has traded between ₹129.11 and ₹290.78.
The stock has recorded a trading volume of 7,318 shares,. Its Average Traded Price (ATP) is ₹186.14, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 9 @ ₹180.69.
Arvee Laboratories (India) has an upper circuit limit of ₹234.30 and a lower circuit limit of ₹156.20. The total value traded stands at ₹13.62 L, and the delivery percentage for the day is 46.6%.
The stock is currently traded with a market lot size of 1. Arvee Laboratories (India) also offers a dividend yield of 0%.
Arvee Laboratories (India) Share Price Chart
Arvee Laboratories (India) Share Key Metrics
Volume
7318.00
Market Cap
199.12 CR
LTQ@LTP
9@180.69
ATP
186.14
Var Margin
29.65 %
Circuit Range
156.2-234.3
Delivery %
46.6 %
Value
13.62 L
ASM/GSM
No
Market Lot
1
Arvee Laboratories (India) Resistance and Support
Pivot 199.85
Resistance
First Resistance
205.7
Second Resistance
216.14
Third Resistance
221.99
Support
First Support
189.41
Second Support
183.56
Third Support
173.12
Arvee Laboratories (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 195 | 180.69 | -7.46% | 195 | 176.5 |
| Thu Sep 10 2026 | 210.28 | 195.25 | -7.15% | 210.28 | 194 |
| Wed Sep 09 2026 | 206 | 210.28 | 8.54% | 224.99 | 206 |
Arvee Laboratories (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results & Others |
| 2026-05-19 | Audited Results & Others |
| 2026-05-18 | Audited Results & Others |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-09 | Audited Results & Others |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Others |
Arvee Laboratories (India) Management
| Name | Position |
|---|---|
| Shalin Sudhakarbhai Patel | Chairman & Managing Director |
| Shalini Hitesh Jalan | Non Executive Independent Director |
Arvee Laboratories (India) Similar Stocks
Nova Agritech Ltd.
22.70
-0.39 (1.69%)
Shree Tirupati Balajee Agro Trading Company Ltd
25.14
-0.39 (1.53%)
Tainwala Chemicals & Plastics (India) Ltd.
207.79
-2.23 (1.06%)
Indian Phosphate Ltd.
75.50
1.10 (1.48%)
Hindustan Adhesives Ltd.
369.10
3.80 (1.04%)
Neochem Bio Solutions Ltd.
102.15
-1.35 (1.30%)
Somi Conveyor Beltings Ltd.
92.93
0.17 (0.18%)
Arvee Laboratories (India) FAQs
The Buying Price of Arvee Laboratories (India) share is 180.69 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Arvee Laboratories (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Arvee Laboratories (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Arvee Laboratories (India) shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Arvee Laboratories (India) shares is 0. Useful to assess the stock's value relative to its book value.
To assess Arvee Laboratories (India)’s valuation compare Sector P/E, P/B which are 50.26 & 2.88 with sector averages, along with growth rates and financial metrics.
The Market Cap of Arvee Laboratories (India) is 199.12 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Arvee Laboratories (India) share price is 290.78 & 129.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Arvee Laboratories (India) belongs to the Chemicals sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ARVEE
